Daniel H Schneiderman - Net Worth and Insider Trading

Daniel H Schneiderman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Daniel H Schneiderman owns 3 companies in total, including Entero Therapeutics Inc (ENTO) , MetaStat Inc (MTST) , and Pasithea Therapeutics Corp (KTTA) .

Click here to see the complete history of Daniel H Schneiderman’s form 4 insider trades.

Insider Ownership Summary of Daniel H Schneiderman

Ticker	Comapny	Transaction Date	Type of Owner
ENTO	Entero Therapeutics Inc	2022-01-03	CHIEF FINANCIAL OFFICER
MTST	MetaStat Inc	2018-01-12	VP OF FINANCE AND SECRETARY
KTTA	Pasithea Therapeutics Corp	2022-08-12	Interim Chief Accting Officer

Daniel H Schneiderman Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Daniel H Schneiderman Ownership Network

Ownership Network List of Daniel H Schneiderman

No Data

Ownership Network Relation of Daniel H Schneiderman

Daniel H Schneiderman Owned Company Details

What does Entero Therapeutics Inc do?

Who are the key executives at Entero Therapeutics Inc?

Daniel H Schneiderman is the CHIEF FINANCIAL OFFICER of Entero Therapeutics Inc. Other key executives at Entero Therapeutics Inc include director & President and CEO James Sapirstein , Chief Financial Officer Sarah Romano , and CHIEF MEDICAL OFFICER James Pennington .

Entero Therapeutics Inc (ENTO) Insider Trades Summary

Over the past 18 months, Daniel H Schneiderman made no insider transaction in Entero Therapeutics Inc (ENTO). Other recent insider transactions involving Entero Therapeutics Inc (ENTO) include a net sale of 8,338 shares made by James Sapirstein , a net sale of 4,944 shares made by Sarah Romano , and a net sale of 6,063 shares made by Charles J Casamento .

In summary, during the past 3 months, insiders sold 3,256 shares of Entero Therapeutics Inc (ENTO) in total and bought 0 shares, with a net sale of 3,256 shares. During the past 18 months, 4,311 shares of Entero Therapeutics Inc (ENTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 4,311 shares.

Entero Therapeutics Inc (ENTO)'s detailed insider trading history can be found in Insider Trading Tracker table.

Entero Therapeutics Inc Insider Transactions

No Available Data

What does MetaStat Inc do?

Who are the key executives at MetaStat Inc?

Daniel H Schneiderman is the VP OF FINANCE AND SECRETARY of MetaStat Inc. Other key executives at MetaStat Inc include and 10 percent owner Richard W Perkins .

MetaStat Inc (MTST) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of MetaStat Inc (MTST) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of MetaStat Inc (MTST) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

MetaStat Inc (MTST)'s detailed insider trading history can be found in Insider Trading Tracker table.

MetaStat Inc Insider Transactions

No Available Data

What does Pasithea Therapeutics Corp do?

Who are the key executives at Pasithea Therapeutics Corp?

Daniel H Schneiderman is the Interim Chief Accting Officer of Pasithea Therapeutics Corp. Other key executives at Pasithea Therapeutics Corp include Chief Development Officer Graeme Martin Currie , 10 percent owner Paul B Manning , and 10 percent owner Bradford Manning .

Pasithea Therapeutics Corp (KTTA) Insider Trades Summary

Over the past 18 months, Daniel H Schneiderman made no insider transaction in Pasithea Therapeutics Corp (KTTA). Other recent insider transactions involving Pasithea Therapeutics Corp (KTTA) include a net purchase of 30,000 shares made by Lawrence Steinman ,

In summary, during the past 3 months, insiders sold 0 shares of Pasithea Therapeutics Corp (KTTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Pasithea Therapeutics Corp (KTTA) were sold and 1,500 shares were bought by its insiders, resulting in a net purchase of 1,500 shares.

Pasithea Therapeutics Corp (KTTA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Pasithea Therapeutics Corp Insider Transactions

No Available Data

Daniel H Schneiderman Mailing Address

Above is the net worth, insider trading, and ownership report for Daniel H Schneiderman. You might contact Daniel H Schneiderman via mailing address: 760 Parkside Ave. Suite 304, Suite 207, Brooklyn Ny 11226.

Discussions on Daniel H Schneiderman

No discussions yet.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.